Effects of aromatic cationic molecules on bovine viral diarrhea virus and embryonic development

• Published in: Theriogenology 2005-04, Vol.63 (7), p.1984-1994
• Main Authors: Givens, M.D., Galik, P.K., Riddell, K.P., Dykstra, C.C., Brock, K.V., Stringfellow, D.A.
• Format: Article
• Language: English
• Subjects: Animals; Antiviral; antiviral agents; Antiviral Agents - pharmacology; antiviral properties; blastocyst; Blastocyst - drug effects; Blastocyst - physiology; Blastocyst - virology; Bovine viral diarrhea virus; Bovine Virus Diarrhea-Mucosal Disease - prevention & control; BVDV; Cations; Cattle; cultured cells; Diarrhea Viruses, Bovine Viral - drug effects; Diarrhea Viruses, Bovine Viral - physiology; dosage; drug evaluation; Embryo; embryo culture; embryogenesis; Embryonic Development - drug effects; Epithelial Cells - virology; Female; Fertilization in Vitro - veterinary; Furans - pharmacology; Imidazolines - pharmacology; IVF; Male; Pestivirus; Pregnancy; Uterus - cytology; Uterus - virology; virus replication; Virus Replication - drug effects
• ISSN: 0093-691X; 1879-3231
• DOI: 10.1016/j.theriogenology.2004.09.004

Bovine viral diarrhea virus (BVDV) has been shown to replicate in embryo culture systems and remain associated with bovine embryos developing in vitro. In this study, novel antiviral agents were evaluated for capability to inhibit replication of BVDV without affecting embryonic development. Serial concentrations of 2-[5(6)-{2-imidazolinyl}-2-benzimidazolyl]-5-(4-aminophenyl)furan (DB456) or 2-(4-[2-imidazolinyl]phenyl)-5-(4-methoxyphenyl)furan (DB606) were prepared in IVC medium. Then, bovine uterine tubal epithelial cells (UTC) were placed in IVC media with varying concentrations of DB456 or DB606. Within 1 h, a genotype I or II strain of BVDV was added to the cultures. Cultures were maintained for 7 days. Infectious virus was quantitated in IVC media collected on days 3 and 7 and in UTC lysates harvested on day 7. The effective antiviral concentrations of DB606 were much lower than effective antiviral concentrations of DB456. In subsequent experiments, IVF presumptive zygotes were cultured in IVC medium with or without DB456 or DB606 at multiple concentrations for 7 days to evaluate effect of the compound on conceptus development. On day 7, stage of embryonic development was observed, and blastocysts were harvested and stained using Hoechst 33342 to enumerate embryonic cells. While DB456 inhibited blastocyst development, DB606 at 20 times the effective antiviral concentration did not hinder blastocyst development or reduce the mean number of cells per blastocyst. These preliminary results indicated that bovine embryo cultures might be safely supplemented with effective concentrations of an antiviral agent.